In the striatum, histamine H 3 receptors (H 3 Rs) are co-expressed with adenosine A 2A receptors (A 2A Rs) in the cortico-striatal glutamatergic afferents and the GABAergic medium-sized spiny neurons that originate the indirect pathway of the basal ganglia. This location allows H 3 Rs and A 2A Rs to regulate the striatal GABAergic and glutamatergic transmission. However, whether these receptors can physically interact has not yet been assessed. To test this hypothesis, a heteromer-selective in vitro assay was used to detect functional complementation between a chimeric A 2A R 302 -G␣ qi4 and wild-type H 3 Rs in transfected HEK-293T cells. H 3 R activation with the agonist RAMH resulted in Ca 2+ mobilization (pEC 50 7.31 ± 0.23; maximal stimulation, Emax 449 ± 25% of basal) indicative of receptor heterodimerization. Functional H 3 R-A 2A R heteromers were confirmed by co-immunoprecipitation and observations of differential cAMP signaling when both receptors were co-expressed in the same cells. In membranes from rat striatal synaptosomes, H 3 R activation decreased A 2A R affinity for the agonist CGS-21680 (pKi values 8.10 ± 0.04 and 7.70 ± 0.04). Moreover, H 3 Rs and A 2A Rs co-immunoprecipitated in protein extracts from striatal synaptosomes. These results support the existence of a H 3 R-A 2A R heteromer with possible physiological implications for the modulation of the intra-striatal transmission.
Introduction
The actions of histamine in the periphery on airway constriction, inflammation and gastric acid secretion are well known, whereas its function in the Central Nervous System (CNS) is not yet fully understood. In mammals, histamine actions are mediated by four (H 1 R-H 4 R) G protein-coupled receptors (GPCRs), of which the H 3 receptor (H 3 R) displays the highest expression in the brain. In the CNS, histamine is released from the terminals and dendrites of neu-
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rons located in the hypothalamic tuberomammilary nucleus, from where they innervate most of the CNS, including nuclei belonging to the basal ganglia, a subcortical group of structures intimately related to the control of motor behavior [1, 2] . The striatum is the main input nucleus of the basal ganglia and integrates motor and sensory information. The primary striatal afferents are glutamatergic axons originating from neurons located in the cerebral cortex and thalamus, and dopaminergic axons of sustantia nigra pars compacta neurons [3] . In turn, the axons of the GABAergic medium-sized spiny neurons (MSNs), which account for more than 90% of the striatal neuronal population [4] , project to the globus pallidus and sustantia nigra pars reticulata [3] .
H 3 Rs are abundantly expressed in the striatum either as presynaptic auto-and hetero-receptors or as post-synaptic receptors, with the latter located on the bodies of the MSNs and GABAergic or cholinergic interneurons [5] [6] [7] . The understanding of the physiological role of striatal H 3 Rs is complicated by their ubiquitous expression and capability to engage in protein-protein interactions with other GPCRs [8] . Of particular interest in the striatum are dopamine and adenosine receptors, which are also highly expressed. Based on the selective expression of dopamine and adenosine receptor subtypes, MSNs can be segregated into two neuronal populations. Neurons that originate the basal ganglia direct pathway (dMSNs) are identified by the expression of D 1 -like receptors (D 1 Rs) whereas the indirect pathway population (iMSNs) is formed by neurons expressing adenosine A 2A receptors (A 2A Rs) and D 2 -like receptors (D 2 Rs) [9, 10] . In the striatum, H 3 Rs have been shown to form heterodimeric protein-protein complexes with dopamine D 2 and D 1 receptors [11] , and heterotrimers with 1/D 1 receptors and NMDA/D 1 receptors [12, 13] . In turn, A 2A Rs can form dimers with D 2 , cannabinoid CB 1 and adenosine A 1 receptors [14] [15] [16] and oligomers with D 2 and mGlu5 glutamate receptors [17] .
Both H 3 and A 2A receptors modulate intra-striatal synaptic transmission. The activation of the G␣ i/o -coupled H 3 Rs results in inhibition of GABA, dopamine, acetylcholine and glutamate release [18] [19] [20] [21] , whereas the activation of the G␣ s -coupled A 2A Rs also inhibits GABA release but facilitates glutamatergic cortico-striatal transmission [22, 23] .
Either individually or through their heteromeric interactions with other GPCRs, A 2A Rs and H 3 Rs have been proposed as targets for the treatment of basal ganglia-related disorders such as Parkinson's disease and addiction [11, [24] [25] [26] . In this work, we hypothesized that striatal H 3 Rs and A 2A Rs can not only form heteromers with dopamine receptors, but also with each other, and that this interaction forms a unique pharmacological target that could be of potential therapeutic interest. Here we show that H 3 Rs co-immunoprecipitate with A 2A Rs in HEK293T cells, suggestive of oligomerization. Further, we studied the physical properties of the A 2A R-H 3 R interaction by a functional complementation assay. We next showed that the A 2A R-H 3 R heteromerization has unique functional pharmacology in terms of cAMP modulation in HEK-293T cells co-expressing the receptors. Using protein extracts from striatal synaptosomes, we confirmed the presence of A 2A R-H 3 R heteromers in vivo by co-immunoprecipitation. Finally, we found that in the same preparation H 3 R activation resulted in decreased binding affinity of A 2A R for the agonist CGS-21680.
A preliminary account of this work was presented in the abstract form to the European Histamine Research Society [27] and submitted to an electronic pre-print server [46] .
Methods

Materials
The following drugs and reagents were purchased from Sigma Aldrich (St. Louis, MO, USA): (R)(−)-␣-methylhistamine dihydrochloride, histamine dihydrochloride, adenosine deaminase (from bovine spleen), Percoll, quinpirole dihydrochloride. Dimaprit was from Axon MedChem (Reston, VA, USA). CGS-21680 was from Cayman Chemical (Ann Arbor, MI, USA). N-␣-[methyl-3 H]-histamine (78.3 Ci·mmol −1 ) and CGS-21680-[carboxyethyl-3 H (N)]-(35.2 Ci·mmol −1 ) were from Perkin Elmer (Boston, MA, USA).
Molecular cloning
Truncated A 2A or H 3 receptors were generated by PCR using the primers indicated in Supplementary Table 1 . After amplification and restriction with HindIII and BamHI enzymes, the truncated A 2A and H 3 receptors were ligated to a pcDNA3.1 plasmid that contained the chimeric G␣ qs4 and G␣ qi4 proteins. Both A 2A Rs and H 3 Rs (cDNA Resource Center, Bloomsberg, PA, USA) were labeled with a triple hemagglutinin tag (3xHA). To generate the 3xHA tagged receptors, the A 2A R and the H 3 R were amplified from nucleotide 377 and 458, respectively, towards their amino terminus. The 3xHA tag was amplified from a plasmid that codified for the tagged human histamine H 4 receptor (3xHA-H 4 R in pcDNA3.1, cDNA Resource Center). The amplified DNA fragments (3xHA-A 2A R377/H 3 R458) where then re-introduced into the pcDNA3.1-H 3 R or pcDNA3.1-A 2A R backbone to obtain the tagged, full length receptors. The insertion and orientation of the amplified fragment was verified by automated sequencing performed at FESI-UNAM (Los Reyes Iztacala, Estado de México, México).
Cell culture and transfection
HEK-293T cells (American Type Culture Collection, Manassas, VA, USA) were grown in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), penicillin (50 UI/ml) and streptomycin (0.1 mg/ml) under a humidified atmosphere (5% CO 2 in air) at 37 • C.
For transfections, cells were seeded in 6-well plates (6 × 10 5 cells/well; up to passage 15) and incubated for 24 h at 37 • C in a 5% CO 2 /air mixture. The next day, 10 l X-tremeGENE (Roche, Basilea, Switzerland) were mixed with 500 l Optimem (Life Technologies, San Diego, CA, USA) and the mixture was incubated for 5 min at room temperature before the addition of cDNA in a 1:5 ratio with X-tremeGENE. For cAMP assays a mixture of DNA:Glosensor cAMP plasmid (1:2 ratio) was added to the Optimem/X-tremeGENE solution. When plasmids containing the A 2A R or H 3 R were transfected alone, the amount of DNA was preserved by adding empty pcDNA3.1 vector. The transfection mixture was incubated for 20 min at room temperature and then added to the cells, which were incubated for 24 h at 37 • C under a humidified atmosphere (5% CO 2 /air).
For co-immunoprecipitation assays, HEK-293T cells, grown in 100-millimeter Petri dishes and at 80% confluence, were transfected using the Lipofectamine 2000 method. Briefly, a mixture of DNA/Lipofectamine 2000 (1:2 ratio) was incubated for 20 min at room temperature before being added to the cells. After incubation for 5 h at 37 • C under a humidified atmosphere (5% CO 2 /air), the medium was replaced by high-glucose DMEM supplemented with 10% FBS and 1% antibiotic/antimycotic. Incubation continued for a further 24 h under the same condition.
cAMP accumulation assay
cAMP assays were performed as described in detail elsewhere [28] . Briefly, HEK-293T cells transfected with 3xHA-A 2A R, 3xHA-H 3 R or a mixture of both plasmids (1 g each) together with Glosensor cAMP plasmid (Promega, Madison, WI, USA) were seeded in a white 384-well low-volume plate (25,000 cells/well in 7.5 l medium) and incubated with Glo-equilibrium medium (7.5 l, Promega). Drugs under test were added in a 5 l volume (4 x in HBSS solution) and endogenous cAMP luminescence was measured in real-time in a Flexstation 3 apparatus (Molecular Devices, Sunnyvale, CA, USA).
Calcium mobilization assay
HEK-293T cells transfected with 1 g of DNA were seeded (2.5 × 10 4 cells/well) in a 384-well clear bottom black plate (25 lvolume) and incubated for 24 h at 37 • C in a humidified 5% CO 2 /air atmosphere, covered with Areaseal film (Sigma, St. Louis, MO, USA). Cells were then loaded with 25 l of the FLIPR Ca 2+ dye (Molecular Devices, Sunnyvale, CA, USA) and incubated for 1 h at 37 • C. Agonists were added in a 20 l volume and calcium mobilization was measured in real-time for 2 min in a Flexstation 3 apparatus (Molecular Devices, Sunnyvale, CA, USA) and analyzed as described in detail in [29] .
Synaptosome preparation
All procedures were approved and controlled by the Cinvestav Animal Care Committee and were in accord with the rules issued by the National Institutes of Health (NIH Publications No. 8023) and the Mexican Council for Animal Care. Wistar rats (males, 250-300 g, provided by Unidad de Producción y Experimentación para Animales de Laboratorio; Cinvestav, Mexico City) were decapitated, the brain was quickly removed from the skull and the forebrain was separated and deposited on a metal plate placed on ice. The striata from 3 to 5 animals were dissected using forceps and the whole tissue was placed in 5 ml 0.32 M sucrose solution containing 10 mM Hepes, 1 mg/ml bovine serum albumin and 1 mM EDTA (pH 7.4 with NaOH). The tissue was homogenized using 10 strokes of a hand-held homogenizer (400 rpm), the homogenate was centrifuged (1000xg, 10 min, 4 • C) and the supernatant was pelleted at 14,000xg (12 min, 4 • C). The pellet was re-suspended in 5 ml of a Percoll solution (45%, v:v) in Krebs-Henseleit-Ringer buffer (in mM: NaCl 140, Hepes 10, D-glucose 5, KCl 4.7, EDTA 1, pH 7.3 with NaOH). After centrifugation (2 min, 14,000xg, 4 • C), the upper phase was collected and brought up to 20 ml with Krebs-Ringer-Hepes (KRH) solution (in mM: NaCl 113, NaHCO 3 
Transmission electron microscopy (TEM)
Striatal synaptosomes were isolated by the Percoll method as above. Sample preparation and TEM were performed as described in detail elsewhere [30] .
Radioligand binding assays with striatal membranes
Striatal synaptosomes were re-suspended in lysis solution (TrisHCl 10 mM, EGTA 1 mM, pH 7.4) and incubated for 20 min at 4 • C before centrifugation (20 min, 20,000xg, 4 • C). The pellet (synaptosomal membranes) was re-suspended in 1 ml KRH solution containing adenosine deaminase (2 U/ml). After incubation for 30 min at 37 • C, the suspension was brought to 20 ml with KRH solution and centrifuged (20 , incubations were stopped by rapid filtration through Whatman GF/B filters pre-soaked (2 h) in 0.3% polyethylenimine (PEI). Filters were washed 3 times with 1 ml ice-cold buffer solution (50 mM Tris-HCl, pH 7.4), soaked in 4 ml scintillation solution and the tritium content was determined by scintillation counting.
Co-immunoprecipitation assays
Striatal synaptosomes were obtained as described above and then re-suspended in 1 ml of lysis solution (Tris-HCl 50 mM, NaCl 150 mM, Triton X-100 1%, SDS 0.05%, protease inhibitor 1 l/ml). HEK-293T cells were dislodged in RIPA solution. For both synaptosomal and cell samples, protein was extracted by sonication (3 cycles, 30 s, 8 kHz). The sample was centrifuged (20 min, 6,000xg) and the protein extract (supernatant) was collected. Nonspecific binding was removed by incubation (1 h, 4 • C) with 10 l of AG beads (Santa Cruz Biotechnology; Dallas, TX, USA) under rotatory rocking. The beads were pelleted (2 min, 6000xg) and the supernatant was used for the assay. Protein quantification was performed by the BCA method.
The protein extracts (500 g protein from striatal synaptosomes and 200 g from HEK-293T cells) were incubated with 2 g of the primary antibodies (anti-A 2A R Abcam, cat. ab3461, lot. GR238882-9; anti-H 3 R, Abcam, cat. ab84468, lot. GR27494-1, in a 1:100 dilution) together with AG beads (Santa Cruz Biotechnology sc-2003, 1:5 antibody to beads ratio) for 16 h at 4 • C with constant rotational rocking. Antibodies against the CD-81 protein (Santa Cruz Biotechnology, cat. sc-70803, lot. B0609) or D 2 R (Santa Cruz Biotechnology, cat. sc-5303, lot. A03013) were used as negative controls for the striatal synaptosomes or HEK-293T cells, respectively. The bead-antibody complex was pelleted (2 min, 6000xg) and a 30 l aliquot of the supernatant was used as a load control. In both protein extracts, 30 l of the total protein was used as input. The complex was dissociated for 60 min at 48 • C in loading buffer (10% ␤-mercaptoethanol and 50% Laemmli buffer in H 2 O) and separated by electrophoresis in a 10% SDS-polyacrylamide gel (20 min at 80 V and then 65 min at 120 V). Semi-dry transfer was performed at 15 V for 95 min. Membranes were blocked with 5% nonfat dry milk diluted in TBS-Twin 0.05% solution (overnight, 4 • C). After extensive washing, 5 ml of TBS-Twin 0.05% solution containing 5% BSA and the blotting antibody (anti-A 2A R, anti-HA, Cell Signaling, cat. C29F4, lot. 3724S or anti-H 3 R, in a 1:1000 dilution) were added to the membrane and incubated overnight at 4 • C. Membranes were incubated with the secondary antibody (Invitrogen, HRP-conjugated anti-rabbit IgG, cat. 65-6120, 1:5000, non-fat dry milk 5% in TBSTwin 0.05%) at room temperature for 2 h. For the loading controls membranes were incubated for 1 h with antibodies directed to ␤-tubulin (Invitrogen, cat. 322600, lot. 1235662) or ␣-actin (Sigma, cat. A5228, lot. 128K4843) in a 1:5000 dilution in TBST 0.05%. After washing, membranes were incubated for 1 h with the secondary antibody (␣-mouse, Santa Cruz, cat. sc-2005) diluted in TBST 0.05%. Blot images were obtained by chemiluminescence in an X-ray film (Kodak).
Statistical analysis
Data show the mean ± standard error of the mean (SEM). Statistical analysis was performed with student t-test with Prisma GraphPad software, version 5.0 (San Diego, CA, USA).
Results
Co-immunoprecipitation of A 2A Rs and H 3 Rs expressed in HEK-293T cells
We first studied by co-immunoprecipitation whether H 3 Rs and A 2A Rs interact physically upon co-transfection in HEK-293T cells. 3xHA-H 3 Rs were detected after immunoprecipitation of wild type (WT) A 2A Rs (Fig. 1A) . HEK-293T cells lack expression of the D 2 R, and an antibody targeting this receptor was therefore used as a negative control, yielding no signal. This result supports dimerization between H 3 Rs and A 2A Rs.
Functional complementation of A 2A Rs and H 3 Rs expressed in HEK-293T cells
To further study the potential interaction between A 2A Rs and H 3 Rs in a recombinant cell system, we employed a functional complementation assay, previously used to study physical interactions between GPCRs [29, 31] . This assay relies on the fusion of chimeric G␣ qs4 or G␣ qi4 proteins to the truncated C-terminal tail of a GPCR to generate a nonfunctional receptor, rescuable through homo-or hetero-dimerization with a WT, untruncated receptor. It was previously reported that fusion of a chimeric G protein to a GPCR truncated near helix 8 produces a receptor that is unable to signal by itself but can be rescued when transfected with a full-length receptor [29] . Therefore, we first generated an A 2A R truncated to 302 residues (A 2A R 302 ) and H 3 Rs of 427, 421 and 411 residues (H 3 R 427 , H 3 R 421 and H 3 R 411 ), and the truncated receptors were then fused to the chimeric G proteins ( Fig. 2A) .
Activation of the H 3 R in transfected CHO-K1 cells and rat striatal neurons in primary culture induces Ca 2+ mobilization [32, 33] , and in the striatum A 2A R activation favors Ca 2+ entry by modulating voltage-activated Ca 2+ channels [34, 35] , which are endogenously expressed by HEK-293T cells [36, 37] . In HEK-293T cells, the H 3 R selective agonist RAMH did not induce any discernible Ca 2+ response but did so when the H 3 R was co-transfected with G␣ qi4 proteins (Fig. 2B) . The A 2A R did not induce Ca 2+ signaling when activated by the selective agonist CGS-21680, but also no response was observed when co-transfected with G␣ qs4 proteins, suggesting that A 2A Rs do not activate this chimeric protein (Fig. 2C) . It has been reported that not all GPCRs are amenable to signal through chimeric G-proteins [38] . A different G␣ s -coupled receptor, the histamine H 2 receptor, was capable to induce Ca 2+ release when co-transfected with G␣ qs4 proteins and stimulated with the selective agonist dimaprit ( Supplementary Fig. 1A ), discarding G␣ qs4 malfunction. Consistent with the finding that A 2A Rs did not signal efficiently via chimeric G-proteins, functional complementation by homodimerization of A 2A R 302 -G␣ qs4 or A 2A R 302 -G␣ qi4 with the full-length A 2A R was not observed (Fig. 2D) .
The C-tail of the H 3 R was truncated such that the H 3 R-G␣ qi4 fusion protein would display limited Ca 2+ mobilization when expressed alone, but a pronounced Ca 2+ signaling when coexpressed with WT-H 3 Rs. The H 3 R 421 -G␣ qi4 and the H 3 R 411 -G␣ qi4 constructs did not induce Ca 2+ mobilization, and could not be rescued via homo-dimerization with WT-H 3 Rs (Supplementary Fig.  1B ). However, Ca 2+ mobilization induced by H 3 R 427 -G␣ qi4 upon activation and co-transfection with WT-H 3 Rs produced a similar increase in Ca 2+ release (Fig. 2E) . While not optimal, this behavior allowed for the study of the interaction between the H 3 R 427 -G␣ qi4 and the A 2A R as described below.
Co-transfection of the 'inert' A 2A R 302 -G␣ qi4 and H 3 Rs induced Ca 2+ mobilization after activation of the latter receptors with RAMH, suggestive of close physical proximity between the H 3 R and both the A 2A R and the fused G␣ qi4 -protein. (Fig. 3A) . Given that H 3 Rs are G␣ i/o -coupled, and the inability of the A 2A R to signal through chimeric G␣ qi4 -or G␣ qs4 -proteins, it was not surprising that A 2A R activation with the selective agonist CGS-21680 did not produce any response through H 3 R 427 -G␣ qs4 or H 3 R 427 -G␣ qi4 (Fig. 3B) . Interestingly, the co-expression of WT-A 2A Rs prevented RAMH-induced Ca 2+ mobilization mediated by the H 3 R 427 -G␣ qi4 (compare Fig. 2E and Fig. 3C ). We briefly explored this pharmacological response further by analyzing Ca 2+ mobilization in HEK-293T cells co-expressing the H 3 R 427 -G␣ qi4 and the A 2A R or the A 2A R 302 -G␣ qi4 and the H 3 R and activating both receptors, but did not observe any additive or antagonistic effect ( Supplementary Fig. 1C and 1D) .
A 2A Rs have been shown to form heteromers with D 2 Rs [39] and robust functional complementation was accordingly observed when A 2A R-G␣ qi4 was co-expressed with WT-D 2 Rs (Fig. 3D) , supporting that our results are due to heterodimerization and not to stochastic interactions (Table 1 ).
The putative A 2A R-H 3 R heteromer displays ligand bias
To test for the selective nature of the A 2A R-H 3 R interaction in the functional complementation assay, we investigated if A 2A R-G␣ qi4 would also allow the structurally and physiologically similar histamine H 4 receptor (H 4 R) to induce Ca 2+ signaling. Co-activation with histamine of H 3 Rs and H 4 Rs elicited Ca 2+ mobilization only when co-transfected with G␣ qi4 (Supplementary Fig. 2A and 2B , respectively). Neither histamine nor RAMH induced Ca 2+ mobilization when the H 4 R was co-expressed with A 2A R 302 -G␣ qi4 , supporting the specificity of the A 2A R-H 3 R interaction (Fig. 3E) . Unexpectedly, whereas RAMH induced Ca 2+ mobilization when the H 3 R was co-expressed with A 2A R 302 -G␣ qi4 , histamine did not (compare Fig. 3A with Fig. 3F ). This result suggests that the A 2A R-H 3 R heteromer displays agonist bias.
A 2A R-mediated signaling is increased by H 3 R co-activation
To study the pharmacology of the putative A 2A R-H 3 R heteromer we next tested cAMP signaling using WT receptors in HEK-293T cells. In cells transfected with the A 2A R, incubation with CGS-21680 resulted in a concentration-dependent increase in cAMP levels in accordance with the receptor's coupling to the G␣ s signaling pathway (Fig. 3A) . CGS-21680 induced a similar cAMP response in HEK293T-A 2A R cells co-expressing H 3 Rs (Fig. 4A) . Co-activation of the receptors resulted in a decrease in baseline, in agreement with the G␣ i/o coupling of the H 3 R, but led to an augmentation of A 2A R-mediated cAMP formation as noticed by a 2.5-fold change of baseline (versus 1.5-fold in control). This result suggests that the A 2A R signaling becomes more efficacious when heterodimerization with the H 3 R occurs (Fig. 4A, Supplementary Fig. 2C , and Table 2 ). The increase in the A 2A R signaling was not observed in the absence of RAMH (1.5-fold of baseline) suggesting an agonist-dependency of the response (Fig. 4A and Supplementary Fig. 2C) .
In HEK293T-H 3 R cells, RAMH inhibited forskolin-stimulated cAMP formation congruent with the G␣ i/o coupling of the H 3 R receptor. However, when the A 2A R was co-transfected, RAMHmediated H 3 R signaling shifted to facilitate cAMP formation instead. Activation of the A 2A R caused an expected increase in the baseline but did not significantly modify the effect on cAMP formation. This result suggests that in the heterodimer, A 2A R signaling prevails over the H 3 R signaling ( Fig. 4B and Supplementary Fig. 2D ; Table 2 ). A. Basis of the assay. The G protein-coupled receptor (GPCR; grey cylinders) is truncated at its carboxyl terminus to generate a nonfunctional GPCR, which is then fused to the chimeric G protein (green hexagons). The chimeric G protein is formed by a G␣q protein in which 9 or 10 residues of the C-terminus were substituted by the corresponding sequence of a G␣s4 or G␣ i4 protein (represented by X). Under these conditions, Ca 2+ mobilization can only be elicited when the complex GPCR-G␣qx is in close proximity to a wild type (WT) GPCR, either the same (homodimerization) or a different receptor (heterodimerization). B. Activation of the H3R with its agonist RAMH resulted in Ca 2+ mobilization only when it was co-expressed with the chimeric G␣ qi4 but not when transfected alone. C. When activated with its agonist CGS-21680, the A 2A R was uncapable to induce Ca 2+ mobilization either alone or when co-transfected with the chimeric G␣qs4 protein. D. Functional complementation by homodimerization of the truncated A 2A R302, either bound to G␣qs4 (A 2A R302-G␣qs4) or G␣ qi4 (A 2A R302-G␣ qi4 ), with the native A 2A R was not observed. E. Activation of the truncated H3R427 bound to G␣ qi4 (H3R427-G␣ qi4 ) induced Ca 2+ mobilization on its own and homodimerization with the WT-H3R did not modify the response. No signal was observed with activation of the H3R427-G␣qs4 construct when it was co-expressed with the WT-H3R. In all graphs data are means ± SEM from 3 replicates from a representative experiment. Where SEM bars are not visible, they are smaller than the symbol size. The quantitative analysis is shown in Table 1 and Supplementary Table 2 . (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
H 3 R activation decreases A 2A R binding affinity in synaptosomal membranes
The identification of A 2A R-H 3 R heteromers was performed in recombinant cell systems over-expressing the receptors. As previously mentioned A 2A Rs and H 3 Rs are co-expressed in iMSNs and cortico-striatal projections. We therefore used rat striatal synaptosomes to seek for pharmacological traces that supported the existence of native A 2A R-H 3 R dimers.
Electron microscopy confirmed in the purified synaptosomal preparation the vast presence and conserved structure of isolated nerve terminals, characterized by a delimited membrane and the presence of mitochondria and synaptic vesicles ( Supplementary  Fig. 3A and B) . In protein extracts from striatal synaptosomes, immunoprecipitation of the A 2A R resulted in a band of ∼45 kDa, corresponding to the expected migration of the H 3 R. No signal was detected when an irrelevant antibody (␣-CD81) was tested. As a positive control the H 3 R was immunoprecipitated and detected as a band of ∼45 kDa (Fig. 5A) . When the reverse approach was employed and the H 3 R was immunoprecipitated from the striatal protein extracts, a band of ∼45 kDa corresponding to the expected migration of the A 2A R was observed. This band was also observed when the A 2A R was immunoprecipitated as a positive control but not detected in the negative control (Fig. 5B) . This result supports 2+ mobilization was not observed when the WT-A 2A R was co-transfected with the truncated H3R427-G␣qs4 or H3R427-G␣ qi4 , in accord with the incapability of the receptor to activate the chimeric proteins. C. As shown in Fig. 1D , activation of the H3R427-G␣ qi4 resulted in Ca 2+ mobilization, and this response was prevented when it was co-expressed with the WT-A 2A R, suggesting a preference of the H3R427-G␣ qi4 to form heterodimers. D. The wellstudied A 2A R-D2R heterodimer was used as a positive control for these experiments. Activation of the D2R with increasing concentrations of the agonist quinpirole caused marked Ca 2+ mobilization only when co-expressed with the chimeric A 2A R302-G␣ qi4 . E. The histamine H4 receptor (H4R) as a negative control. No functional complementation was observed when the receptor was co-expressed with the A 2A R302-G␣ qi4 , showing the specificity of the A 2A R-H3R interaction. F. Functional complementation between the A 2A R302-G␣ qi4 and the WT-H3R was not observed when the latter receptor was activated with the endogenous agonist histamine. For all graphs data are means ± SEM from 3 replicates from representative experiments. Where SEM bars are not visible, they are smaller than the symbol size. The quantitative analysis is shown in Table 1 and  Supplementary Table 2. that the interaction A 2A R-H 3 R is constitutively present in the striatal nerve terminals.
In binding studies with synaptosomal membranes the A 2A R agonist CGS-21680 (10 and 100 nM) did not affect the affinity of the H 3 R for its agonist RAMH (Fig. 6A) , whereas RAMH (100 nM) decreased by two-fold the affinity of the A 2A R for CGS-21680 (Fig. 6B, 6C and Table 3 ), with no effect on maximal binding (Bmax). This pharmacology appears to be specific for pre-synaptic H 3 Rs and A 2A Rs, because we did not observe a similar decrease in A 2A R affinity for CGS-21680 in membranes from the whole striatum, in which postsynaptic membranes constitute the major component ( Fig. 6D and Table 3 ).
Discussion
The H 3 R has been proposed as a potential novel drug target for the treatment of drug use disorders, depression, schizophrenia, and Parkinson's disease. However, its wide brain expression and effects on other neurotransmitter systems may result in adverse effects when H 3 R selective drugs are administered systemically. The A 2A R has also been proposed as an option for the treatment of Parkinson's disease and possesses a strategic distribution in the striatum for targeting and modulating the cortico-dMSNs projections and the activity of iMSNs. The results presented herein may lead to an Data are means ± SEM from 3 experiments. Statistical comparisons were performed between two agonists for the same transfection, or between the transfection with the chimeric receptor and the transfection of the chimeric receptor plus the wild type receptor. ns, no significant difference, a P < 0.05; b P < 0.01, Student's t test. Both RAMH and CGS-21680 were assayed at 100 nM. RAMH, R-␣-methylhistamine; CGS, CGS-21680. Table 2 . B. H3R activation with RAMH decreased forskolin-induced cAMP formation in accord with the inhibitory nature of the G␣ i/o -coupled receptor. A 2A R expression and receptors co-activation led to a change in the H3R signaling. Data are means ± SEM from 5 replicates from a representative experiments. Where SEM bars are not visible, they are smaller than the symbol size. Values for pIC50 and maximal effect (Imax) are given in Table 2 .
Table 2
Pharmacological characteristics of the cAMP formation assay in transfected HEK-293T cells.
Data are means ± SEM from 3 to 5 experiments. Comparison was performed between the solely transfection of a receptor versus the co-transfection of both receptors. a P < 0.05; b P < 0.01. Student's t test. Both RAMH and CGS-21680 were tested at 100 nM. RAMH, R-␣-methylhistamine; CGS, CGS-21680. a P < 0.001, ns, not significant. CGS, CGS-21680. RAMH (R-␣-methylhistamine) was tested at 100 nM in all the experiments.
alternative to specifically target H 3 Rs located in either iMSNs or cortical afferents synapsing onto dMSNs projections.
A 2A R-H 3 R interaction
The primary finding of this study was the identification, for the first time, of A 2A R-H 3 R heteromers, not only in recombinant cell systems but also in rat striatal nerve terminals.
The basis of the functional complementation assays requires a receptor to be nonfunctional and this was obtained by truncation of the C-terminus. Herein we showed that truncation of the H 3 R from 445 to 411 or 421 residues was sufficient to prevent H 3 Rmediated G protein activation of the H 3 R-G␣ qi4 fusion protein, yet we were unable to functionally rescue its signaling, indicating that the remaining C-tail may be too short to connect with an interacting GPCR. However, truncation to 427 amino acids allowed the H 3 R to remain functional.
Exposure of HEK-293T cells transfected with H 3 R 427 -G␣ qi4 to the H 3 R agonist RAMH resulted in Ca 2+ mobilization (Fig. 1E) . As mentioned in the Results section, this response was not expected. In an optimal scenario, the receptor truncation would have prevented or diminished the receptor capability to activate G proteins and the H 3 R 427 -G␣ qi4 function was expected to be either complemented or increased by the co-expression and co-activation with the WT-H 3 R. However, these conditions allowed for the detection of the loss of H 3 R function with the solely presence of the A 2A R, suggesting a preference of the H 3 R to form hetero-dimers over homo-dimers. It may be possible that truncating the H 3 R at the amino acids 421-427 will result in a receptor short enough to abolish the homo/monomeric signaling, but long enough to functionally complement with a full length GPCR.
In order for a GPCR to activate G proteins, the integrity of helix 8 appears to be required. This structural requirement has been demonstrated for D 1 Rs and opioid and receptors [29] . The H 3 R third intracellular loop also appears to play a key role in the receptor-G protein coupling on the basis of the decreased signaling of the H 3 R 365 isoform, which lacks 80 residues in the third intracellular loop [40] , and reduced signaling was induced by the A280V mutation in the same loop [41] . Further consideration to the H 3 R carboxyl tail should therefore be made when assessing the H 3 R-G protein coupling.
An important issue when describing a novel heterodimer is to show changes in the signaling profiles of the receptors involved in the dimer. In this regard, we found enhanced signaling efficacy of the agonist CGS-21680 when the H 3 R was co-transfected and coactivated in the HEK293T-A 2A R cells. This effect can be explained by a H 3 R-mediated facilitation of the A 2A R-G protein coupling, leading to an increase in the receptor efficacy to activate G␣ s proteins and thus to produce cAMP. Given that in the absence of RAMH, CGS-21680 behaved the same in HEK293T-A 2A R and HEK293T-A 2A R/H 3 R cells, receptor expression does not appear to account for the observed effects.
Canonically H 3 Rs couple to G␣ i/o proteins, which inhibit adenylyl cyclase activity and accordingly activation of the receptor with RAMH leads to a decrease in cAMP formation. Similar to the observed in the Ca 2+ mobilization assays, expression of the A 2A R shifted the H 3 R-mediated cAMP response from inhibition to an increase in the cAMP formation. In the Ca 2+ mobilization assays we did not observe signaling of the H 3 R through G␣ qs4 proteins bound to the truncated A 2A R, and we are thus not considering a H 3 R change in signaling pathways as an explanation for this effect. Therefore, we hypothesized that in the A 2A R-H 3 R heteromer the A 2A R signaling prevails over that of the H 3 R, hampered possibly by a steric impediment. This is in line with the loss of Ca 2+ signaling when the H 3 R-G␣ qi4 was co-expressed with the A 2A R.
An unexpected but interesting finding was the potential biased-signaling at the A 2A R-H 3 R heteromer, as evidenced by the incapability of the endogenous ligand histamine to signal at the A 2A R-H 3 R heteromer compared to the exogenous agonist RAMH. This discrepancy suggests that RAMH induces conformational changes in the H 3 R that allow the interaction to occur, whereas histamine-induced changes appear not sufficient for heteromerization, or at least for the heteromer to signal. Ligand bias could also be explained by agonist residence time, this is, the time that a particular drug remains in its binding pocket and that will directly determine the time that a given receptor maintains an active conformation. The active state induced by histamine may therefore have a shorter duration compared with that induced by RAMH, preventing the former from activating the chimeric G proteins bound to the A 2A R 302 . Binding studies with striatal membranes and histamine show that the first hypothesis holds better because histamine induced an increase in the affinity of the A 2A R for its agonist CGS-21680 ( Supplementary Fig. 4 ), opposite to the decrease in affinity change induced by RAMH in the same preparation. This result suggests that histamine and RAMH lock the H 3 R in different conformational states that affect its interaction with the A 2A R.
Functional relevance of the A 2A R-H 3 R heterodimer
Our results suggest a pre-synaptic location of the A 2A R-H 3 R heterodimer in the striatum. A previous report indicates equal distribution of A 2A Rs in total and synaptosomal membranes from rat striatum [47] , with a preferential location on the post-synaptic density fraction over the pre-synaptic active zone fraction (49.2 ± 3.3% and 26.9 ± 3.3% of total immunoreactivity, respectively). H 3 Rs are expressed pre-and post-synaptically [42] , but they seem to be highly enriched in the terminals of striato-pallidal neurons (iMSNs) yielding a value of 1327 ± 79 fmol/mg protein [30] . This distribution supports our proposal for the heterodimer location and suggests a role for the A 2A R-H 3 R heteromer in the pre-synaptic modulation of glutamatergic and GABAergic transmission.
In the striatum, A 2A Rs have a specific location in iMSNs [9] and cortico-dMSNs terminals, but not in the cortico-iMSNs projections [43] whereas the H 3 R is ubiquitously expressed throughout the striatum [8] . Both receptors can modulate the cortico-striatal glutamatergic and intra-striatal GABAergic transmission, but whereas the H 3 R consistently inhibits neurotransmitter release in either location, the A 2A R facilitates cortico-striatal glutamate release but inhibits GABA release from the iMSNs collaterals.
Our data depicts thus a scenario where the A 2A R and the H 3 R preserve their canonical signaling pathways (G␣ s and G␣ i/o , respectively), and upon dimerization the H 3 R facilitates the A 2A R signaling. This receptor functionality is preserved in the corticodMSNs projections, with A 2A R activation enhancing glutamate release [23] and H 3 Rs exerting the opposite effect [21] . Activation of the A 2A R-H 3 R heterodimer in these terminals may further facilitate glutamate release, resulting in hyper-stimulation of the dMSNs population.
Contrary to the A 2A R and H 3 R antagonic modulation of glutamatergic transmission, both receptors inhibit GABA release from iMSNs collaterals. This may be due to the A 2A R functional duality showed in this neuronal population, as demonstrated by its capability to activate G␣ s and G␣ q proteins [22, 35] . Therefore, we hypothesized that the activation of the A 2A R-H 3 R heterodimer in this location will further inhibit GABA release from iMSN nerve terminals, facilitating the activation of the dMSNs. According to this hypothesis, the overall activation of the striatal A 2A R-H 3 R heterodimer would increase dMSNs activity. It is therefore tempting to speculate that co-activation of the heterodimer may have relevance for the treatment of autism and obsessive and compulsive disorder, in which alterations in cortico-striatal glutamatergic transmission and MSN excitability have been shown [44, 45] .
Furthermore, it has been reported that the A 2A R antagonists KW-6002 and SCH-442416 can distinguish receptors located in the cortical afferents targeting dMSNs or iMSNs, respectively Orrú et al., 2011. Although there are no agonists capable to differentiate between A 2A R populations, this information may be a valuable tool for targeting and modulating the A 2A R and H 3 R pharmacology in a location-specific manner, using bivalent ligands directed to the heterodimer.
Conclusion
This study presents for the first time evidence for an A 2A R-H 3 R heterodimer based on functional complementation and co-immunoprecipitation assays in HEK-293T cells, where coactivation of the receptors leads to enhanced A 2A R signaling and attenuation of H 3 R functionality. In rat striatal tissue, the interaction occurs in synapses where H 3 R activation modifies the binding affinity of the A 2A R. 
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